Delivery Order SPE2DB20D7066-SPE2DB25FC4KN
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Pantoprazole Sodium delayed-release 40 mg tablets in a quantity of 1,000 units, with a contract value of $1,013.16. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively awarded. The order is set for ultimate completion on August 1, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Pantoprazole Sodium delayed-release 40 mg tablets in a 90-count package. This order, valued at $1,120.33, represents a firm fixed-price delivery against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle running through December 2026. The award is non-set-aside and was...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Pantoprazole Sodium delayed-release 40 mg tablets in a quantity of 1,000 units, with a ceiling value of $1,129.71. This contract represents a firm fixed-price delivery order with an ultimate completion date of July 21, 2025, and was awarded without set-aside provisions through open competition. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Pantoprazole Sodium delayed-release 40 mg tablets in a quantity of 1,000 units, with a contract ceiling value of $1,083.78. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The product will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,841.28, is for the supply of 4,562,828,860 units of Pantoprazole Sodium Delayed-Release 40 mg tablets. The contract has a period of performance through November 16, 2023. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the delivery of Pantoprazole Sodium Delayed-Release (DR) 40 mg tablets in 1,000-count bottles. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $7,495.89, and has an ultimate completion date of September 12, 2024. The contract is not set aside for any specific business type. AmerisourceBergen, a major pharmaceutical distributor, will provide these...
- This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp (AmerisourceBergen) for the supply of 4,565,427,748 units of pantoprazole sodium delayed-release 40 mg tablets in 1,000-count bottles. The $4,271.44 firm fixed-price contract has an ultimate completion date of August 13, 2024. This order is not set aside for any small business category. AmerisourceBergen, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) with DLA...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,120.62, is for the delivery of 4,568,142,753 units of Pantoprazole Sodium Delayed-Release 40 mg tablets in 1,000-count bottles. The contract is a firm fixed-price delivery order with a performance period ending on May 6, 2025. AmerisourceBergen Drug Corp is not a small business, and the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $6,292.92, is for the delivery of 4,568,174,061 units of Pantoprazole Sodium Delayed-Release 40 mg Tablets. The contract is a firm-fixed-price delivery order, with a performance period extending through May 8, 2025. This award is not set-aside and represents an open competition. AmerisourceBergen Drug Corp holds a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,856.14, is for the delivery of Pantoprazole Sodium Delayed-Release (DR) 40 mg tablets in quantities of 1,000. The contract has a firm fixed price and an ultimate completion date of July 10, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- SPE2DB20D7066Indefinite Delivery Contract
- SPE2DB20D7066-SPE2DB25FC4KNDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,871.12 to AmerisourceBergen Drug Corp for Pantoprazole Sodium Delayed-Release 40 mg tablets (90-count supply). This competitively awarded, non-set-aside contract carries a firm fixed price and represents a single delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA. The work is to be completed by August 21, 2025, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving federal healthcare systems, including military and veteran programs. This delivery order falls under the company's significant $999,999,999.00 indefinite delivery contract with DLA Troop Support Medical (SPE2DX), which runs through December 2026 and provides comprehensive global pharmaceutical support. The contract vehicle enables AmerisourceBergen to supply a broad range of pharmaceutical products, generic and brand-name medications, vaccines, and medical supplies across multiple therapeutic domains to support Defense Health Agency and other federal healthcare customers worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 8/20/25 |